I agree that this site is using cookies. You can find further informations here.
X
Dumaz, Marie
24  results:
Search for persons X
?
1

Topic modeling in density functional theory on citations of..:

Dumaz, Marie ; Romero-Bohórquez, Camila ; Adjeroh, Donald.
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

Authorship and citation cultural nature in Density Function..:

Dumaz, Marie ; Boucher, Reese ; Marques, Miguel A. L..
Scientometrics.  126 (2021)  8 - p. 6681-6695 , 2021
Link: https://doi.org/10.1007/..
 
?
3

1000 Meisterwerke der Malerei:

Manca, Joseph ; Bade, Patrick ; Costello, Sarah... , 2014
Link: https://search.ebscohost..
 
?
4

Topic Modeling in Density Functional Theory on Citations of..:

Dumaz, Marie ; Romero-Bohorquez, Camila ; Adjeroh, Donald.
http://arxiv.org/abs/2303.10239.  , 2023
Link: http://arxiv.org/abs/230..
 
?
5

Topic modeling in density functional theory on citations of..:

Marie Dumaz ; Camila Romero-Bohórquez ; Donald Adjeroh.
https://doi.org/10.1038/s41598-023-38551-6.  , 2023
Link: https://doi.org/10.1038/..
 
?
6

bibliometric_DFT:

Marie Dumaz (8872211) ; Reese Boucher (8981735) ; Miguel A.L. Marques (7015838).
https://figshare.com/articles/dataset/bibliometric_DFT/12494654.  , 2020
Link: https://doi.org/10.6084/..
 
?
7

The soluble form of CD160 acts as a tumor mediator of immun..:

Gauci, Marie-Léa ; Giustiniani, Jérôme ; Lepelletier, Clémence...
Cancer Immunology, Immunotherapy.  71 (2022)  11 - p. 2731-2742 , 2022
Link: https://doi.org/10.1007/..
 
?
8

A targeted genomic alteration analysis predicts survival of..:

Louveau, Baptiste ; Delyon, Julie ; De Moura, Coralie Reger...
Oncotarget.  10 (2019)  18 - p. 1669-1687 , 2019
Link: https://doi.org/10.18632..
 
?
9

CD160 soluble, un nouveau médiateur de l'échappement tumora..:

Gauci, M.-L. ; Lepelletier, C. ; Giustiniani, J....
Annales de Dermatologie et de Vénéréologie.  145 (2018)  12 - p. S316 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Validation of a preclinical model for assessment of drug ef..:

Delyon, Julie ; Varna, Mariana ; Feugeas, Jean-Paul...
Oncotarget.  7 (2016)  11 - p. 13069-13081 , 2016
Link: https://doi.org/10.18632..
 
?
11

Correction: Validation of a preclinical model for assessmen..:

Delyon, Julie ; Varna, Mariana ; Feugeas, Jean-Paul...
Oncotarget.  7 (2016)  30 - p. 48850-48850 , 2016
Link: https://doi.org/10.18632..
 
?
12

PARKINInactivation Links Parkinson's Disease to Melanoma:

Hu, Hui-Han ; Kannengiesser, Caroline ; Lesage, Suzanne...
Journal of the National Cancer Institute.  108 (2015)  3 - p. djv340 , 2015
Link: https://doi.org/10.1093/..
 
?
13

Inhibition of the Proprotein Convertases Represses the Inva..:

Lalou, Claude ; Scamuffa, Nathalie ; Mourah, Samia...
PLoS ONE.  5 (2010)  4 - p. e9992 , 2010
Link: https://doi.org/10.1371/..
 
?
14

The soluble form of CD160 acts as a tumor mediator of immun..:

Gauci, Marie-Léa ; Giustiniani, Jérôme ; Lepelletier, Clémence...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-022-03199-0.  , 2022
Link: https://hal.science/hal-..
 
?
15

The soluble form of CD160 acts as a tumor mediator of immun..:

Gauci, Marie-Léa ; Giustiniani, Jérôme ; Lepelletier, Clémence...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-022-03199-0.  , 2022
Link: https://hal.science/hal-..
 
1-15